Aviva’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$295K Sell
5,739
-103,367
-95% -$5.32M ﹤0.01% 872
2025
Q1
$6.4M Buy
109,106
+14,043
+15% +$823K 0.02% 515
2024
Q4
$6.85M Buy
95,063
+89,289
+1,546% +$6.43M 0.02% 498
2024
Q3
$462K Sell
5,774
-18
-0.3% -$1.44K ﹤0.01% 818
2024
Q2
$415K Sell
5,792
-32
-0.5% -$2.29K ﹤0.01% 847
2024
Q1
$410K Sell
5,824
-14
-0.2% -$985 ﹤0.01% 895
2023
Q4
$450K Sell
5,838
-8,249
-59% -$636K ﹤0.01% 882
2023
Q3
$959K Sell
14,087
-9,034
-39% -$615K ﹤0.01% 698
2023
Q2
$1.89M Sell
23,121
-135,934
-85% -$11.1M 0.01% 624
2023
Q1
$11.8M Buy
159,055
+125,740
+377% +$9.33M 0.05% 439
2022
Q4
$2.76M Sell
33,315
-7,797
-19% -$646K 0.01% 675
2022
Q3
$2.92M Sell
41,112
-26,568
-39% -$1.89M 0.02% 658
2022
Q2
$5.87M Sell
67,680
-1,512
-2% -$131K 0.03% 547
2022
Q1
$7.49M Buy
69,192
+6,208
+10% +$672K 0.04% 501
2021
Q4
$8.15M Buy
62,984
+15,660
+33% +$2.03M 0.03% 455
2021
Q3
$5.73M Buy
47,324
+26,264
+125% +$3.18M 0.03% 544
2021
Q2
$2.37M Buy
21,060
+8,176
+63% +$920K 0.01% 739
2021
Q1
$1.23M Sell
12,884
-7,828
-38% -$747K 0.01% 801
2020
Q4
$1.64M Sell
20,712
-16,788
-45% -$1.33M 0.01% 732
2020
Q3
$2.32M Buy
37,500
+1,512
+4% +$93.6K 0.01% 673
2020
Q2
$2.38M Sell
35,988
-43,040
-54% -$2.84M 0.01% 595
2020
Q1
$3.75M Buy
79,028
+44,340
+128% +$2.1M 0.03% 515
2019
Q4
$1.9M Buy
+34,688
New +$1.9M 0.01% 771